In MM cells, an increased cytokine stimulation from the TME as well as mutations of genes encoding NFκB proteins and their regulators (NFKB1/2, TRAF2/3, TACI, MAP3K14) lead to the constitutive activation of the pathway [100,101,102]. The gene discussed is NFKB1; the disease is Miyoshi myopathy.